These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25577236)
1. The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. Ilisso CP; Castellano M; Zappavigna S; Lombardi A; Vitale G; Dicitore A; Cacciapuoti G; Caraglia M; Porcelli M Endocrine; 2015 Sep; 50(1):212-22. PubMed ID: 25577236 [TBL] [Abstract][Full Text] [Related]
2. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells. Cave DD; Desiderio V; Mosca L; Ilisso CP; Mele L; Caraglia M; Cacciapuoti G; Porcelli M J Cell Physiol; 2018 Feb; 233(2):1370-1383. PubMed ID: 28518408 [TBL] [Abstract][Full Text] [Related]
3. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity. Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632 [TBL] [Abstract][Full Text] [Related]
4. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity. Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769 [TBL] [Abstract][Full Text] [Related]
5. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408 [TBL] [Abstract][Full Text] [Related]
6. AdoMet triggers apoptosis in head and neck squamous cancer by inducing ER stress and potentiates cell sensitivity to cisplatin. Mosca L; Pagano M; Ilisso CP; Cave DD; Desiderio V; Mele L; Caraglia M; Cacciapuoti G; Porcelli M J Cell Physiol; 2019 Aug; 234(8):13277-13291. PubMed ID: 30575033 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model. Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257 [TBL] [Abstract][Full Text] [Related]
8. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux. Zhang X; Peng X; Yu W; Hou S; Zhao Y; Zhang Z; Huang X; Wu K Cancer Lett; 2011 Aug; 307(2):174-81. PubMed ID: 21536373 [TBL] [Abstract][Full Text] [Related]
9. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death. Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020 [TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Sharma G; Tyagi AK; Singh RP; Chan DC; Agarwal R Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225 [TBL] [Abstract][Full Text] [Related]
13. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways. Park SJ; Wu CH; Safa AR Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586 [TBL] [Abstract][Full Text] [Related]
14. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway. Liu WH; Chang LS Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system. Günthert AR; Gründker C; Bongertz T; Nagy A; Schally AV; Emons G Breast Cancer Res Treat; 2004 Oct; 87(3):255-64. PubMed ID: 15528968 [TBL] [Abstract][Full Text] [Related]
16. Taxol induced apoptosis regulates amino acid transport in breast cancer cells. Wu Y; Shen D; Chen Z; Clayton S; Vadgama JV Apoptosis; 2007 Mar; 12(3):593-612. PubMed ID: 17195090 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842 [TBL] [Abstract][Full Text] [Related]
18. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells. Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells. Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269 [TBL] [Abstract][Full Text] [Related]
20. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines. Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]